JLE

European Journal of Dermatology

MENU

Disseminated Kaposi’s sarcoma after long-term prednisone therapy Volume 7, issue 4, June 1997

Figures

See all figures

Authors
Dermatology Clinic, Collegium Medicum, Jagiellonian University, ul. Kopernika 19, 31-501 Kraków, Poland.

The authors describe the case of iatrogenic, disseminated Kaposi’s sarcoma, in a 63-year-old woman treated for 35 years with prednisone for bronchial asthma. After 26 years of treatment, steroid diabetes mellitus developed. This case supports the view that immunosuppression induced by prednisone may be a risk factor for Kaposi’s sarcoma, probably in genetically susceptible patients.